Table 2 Subanalysis showing the influence of donor transplant, virus types and copies, involved retinal zone and size on the visual outcomes
Subanalysis | Eyes of improvement or stabilization, n (%) | Eyes of deterioration, n (%) | P |
|---|---|---|---|
Donor HLA matching | |||
Matched | 9 (47.37%) | 2 (10.53%) | |
Mismatched | 2 (10.53%) | 6 (31.58%) | 0.022 |
Positive virus in blood | |||
CMV + EBV | 6 (31.58%) | 4 (21.05%) | |
CMV | 5 (26.32%) | 4 (21.05%) | 1.000 |
CMV or EBV virus in vitreous | |||
Positive | 7 (36.84%) | 4 (21.05%) | |
Negative | 4 (21.05%) | 4 (21.05%) | 0.103 |
CMV peak in the blood | |||
CMV copies/ml > 1 × 104 | 6 (31.58%) | 6 (31.58%) | |
CMV copies/ml < 1 × 104 | 5 (26.32%) | 2 (10.53%) | 0.633 |
CMV copies in vitreous | |||
CMV copies/ml in vitreous > 1 × 104 | 1 (5.26%) | 8 (42.11%) | |
CMV copies/ml in vitreous < 1 × 104 | 10 (52.63%) | 0 (0) | 0.000 |
Involved zone | |||
Involved 3 zones | 2 (10.53%) | 5 (26.32%) | |
Involved 1 or 2 zones | 9 (47.37%) | 3 (15.78%) | 0.074 |
Sizes of lesions | |||
Sizes of lesions > 50% | 2 (10.53%) | 5 (26.32%) | |
Sizes of lesions < 50% | 9 (47.37%) | 3 (15.78%) | 0.074 |